|
A more recent version of this article appeared on October 1, 2006
Papers In Press, published online ahead of print July 17, 2006
J. Lipid Res., doi:10.1194/jlr.M600269-JLR200
Submitted on June 20, 2006
Revised on July 17, 2006
Accepted on July 17, 2006
Docosahexaenoic acid inhibits growth of mouse mammary cancer cells by interfering with p27/kip1, Cdk2, ERK1/ERK2 and retinoblastoma phosphorylation
Naim A. Khan, Kazuhiro Nishimura, Virginie Aires, Tomoko Yamashita, David Oaxaca-Castillo, Keiko Kashiwagi, and Kazuei Igarashi
Physiologie, Université de Bourgogne, Dijon 21000
Corresponding Author: Naim.Khan{at}u-bourgogne.fr
Docosahexaenoic acid (DHA), a polyunsaturated fatty acid of n-3 family, inhibited growth of FM3A mouse mammary cancer cells by arresting their progression from late-G1 to S phase of cell cycle. DHA upregulated p27Kip1 levels by inhibiting phosphorylation of mitogen-activated protein (MAP) kinases, i.e., ERK1/ERK2. Indeed, inhibition of ERK1/ERK2 phosphorylation by DHA, U0126 (chemical MEK inhibitor) and MEKSA (cells expressing dominant negative constructs of MEK) resulted in the accumulation of p27Kip1. MAPK inhibition by DHA did not increase p27Kip1 mRNA levels rather this fatty acid stabilized p27Kip1 contents and inhibited MAPK-dependent proteasomal degradation of this protein. DHA also diminished cyclin E phosphorylation, cyclin-dependent kinase 2 (CDK2) activity and phosphorylation of retinoblastoma protein (pRb) in these cells. Our study shows that DHA arrests cell growth by modulating the phosphorylation of cell cycle-related proteins.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Gleissman, R. Yang, K. Martinod, M. Lindskog, C. N. Serhan, J. I. Johnsen, and P. Kogner
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates
FASEB J,
March 1, 2010;
24(3):
906 - 915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yessoufou, A. Ple, K. Moutairou, A. Hichami, and N. A. Khan
Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells
J. Lipid Res.,
December 1, 2009;
50(12):
2377 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gorjao, S. M. Hirabara, T. M. de Lima, M. F. Cury-Boaventura, and R. Curi
Regulation of interleukin-2 signaling by fatty acids in human lymphocytes
J. Lipid Res.,
September 1, 2007;
48(9):
2009 - 2019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lopez, B. Bermudez, Y. M. Pacheco, G. Lopez-Lluch, W. Moreda, J. Villar, R. Abia, and F. J. G. Muriana
Dietary Oleic and Palmitic Acids Modulate the Ratio of Triacylglycerols to Cholesterol in Postprandial Triacylglycerol-Rich Lipoproteins in Men and Cell Viability and Cycling in Human Monocytes
J. Nutr.,
September 1, 2007;
137(9):
1999 - 2005.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|